Traders Buy Shares of Monsanto Co. (MON) on Weakness Following Insider Selling
Investors bought shares of Monsanto Co. (NYSE:MON) on weakness during trading hours on Thursday after an insider sold shares in the company. $52.34 million flowed into the stock on the tick-up and $36.69 million flowed out of the stock on the tick-down, for a money net flow of $15.65 million into the stock. Of all stocks tracked, Monsanto had the 19th highest net in-flow for the day. Monsanto traded down ($0.07) for the day and closed at $100.66Specifically, EVP Steven Mizell sold 310 shares of the firm’s stock in a transaction that occurred on Monday, October 10th. The shares were sold at an average price of $103.09, for a total transaction of $31,957.90. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP Robert T. Fraley sold 80,631 shares of the firm’s stock in a transaction that occurred on Friday, October 14th. The stock was sold at an average price of $102.04, for a total transaction of $8,227,587.24. Following the sale, the executive vice president now owns 38,711 shares in the company, valued at approximately $3,950,070.44. The disclosure for this sale can be found here. 0.88% of the stock is currently owned by corporate insiders.
MON has been the topic of a number of recent analyst reports. TheStreet cut shares of Monsanto from a “buy” rating to a “hold” rating in a research note on Monday, September 12th. Citigroup Inc. raised their target price on shares of Monsanto from $112.00 to $116.00 and gave the stock a “neutral” rating in a research note on Friday, August 19th. Zacks Investment Research cut shares of Monsanto from a “hold” rating to a “strong sell” rating in a research note on Friday, October 7th. Monness Crespi & Hardt decreased their target price on shares of Monsanto from $130.00 to $128.00 and set a “buy” rating on the stock in a research note on Monday, October 3rd. Finally, JPMorgan Chase & Co. set a $128.00 target price on shares of Monsanto and gave the stock a “buy” rating in a research note on Thursday, October 6th. Three equities research analysts have rated the stock with a sell rating, eight have issued a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the company. Monsanto has an average rating of “Buy” and a consensus target price of $114.65.
The firm’s 50 day moving average is $101.15 and its 200-day moving average is $103.51. The stock has a market capitalization of $44.33 billion, a PE ratio of 33.87 and a beta of 1.01.
Monsanto (NYSE:MON) last issued its earnings results on Wednesday, October 5th. The company reported $0.07 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.02) by $0.09. Monsanto had a return on equity of 46.07% and a net margin of 9.89%. The business earned $2.56 billion during the quarter, compared to the consensus estimate of $2.38 billion. During the same period last year, the company earned ($0.19) EPS. The company’s revenue for the quarter was up 8.8% on a year-over-year basis. Analysts anticipate that Monsanto Co. will post $4.73 EPS for the current fiscal year.
Hedge funds have recently modified their holdings of the company. Vanguard Group Inc. increased its stake in shares of Monsanto by 1.3% in the second quarter. Vanguard Group Inc. now owns 30,430,570 shares of the company’s stock worth $3,146,826,000 after buying an additional 389,914 shares during the period. FMR LLC increased its stake in shares of Monsanto by 41.3% in the second quarter. FMR LLC now owns 16,593,757 shares of the company’s stock worth $1,715,960,000 after buying an additional 4,851,499 shares during the period. Massachusetts Financial Services Co. MA increased its stake in shares of Monsanto by 0.3% in the second quarter. Massachusetts Financial Services Co. MA now owns 14,893,956 shares of the company’s stock worth $1,540,185,000 after buying an additional 38,316 shares during the period. BlackRock Institutional Trust Company N.A. increased its stake in shares of Monsanto by 1.3% in the third quarter. BlackRock Institutional Trust Company N.A. now owns 11,359,066 shares of the company’s stock worth $1,160,897,000 after buying an additional 140,637 shares during the period. Finally, Capital International Investors increased its stake in shares of Monsanto by 6.2% in the second quarter. Capital International Investors now owns 8,187,701 shares of the company’s stock worth $846,690,000 after buying an additional 476,848 shares during the period. 78.72% of the stock is owned by institutional investors and hedge funds.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Stock Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related stocks with our FREE daily email newsletter.